Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...
Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...
Illumina lowered its adjusted profit outlook and cut spending cost for 2025 as the company grapples with Chinese ban on its ...
Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...
The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...
Health care giant Roche announced its plans recently for a new kind of sequencing analysis ... could lose more than $100 ...
Illumina (NASDAQ ... It also said it is instituting a $100 million cost reduction program for fiscal 2025. "Our new fiscal 2025 guidance provides for limited further earnings contribution from ...
Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...
and Illumina expects its new NovaSeq X Series to enable the $100 genome, which could greatly increase the accessibility of genomic sequencing. At a lower cost, genomic sequencing could even have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results